A PhD on antibiotic resistance
Rebekka Rolfsnes is doing her PhD with the start-up AdjuTec Pharma AS and the Department of Pharmacy at the University of Oslo (UiO). Together, they will look for solutions to antibiotic resistance.
Wenche Gerhardsen is Head of Communications at Oslo Cancer Cluster and Oslo Cancer Cluster Incubator. You can reach her at wg@oslocancercluster.no
Rebekka Rolfsnes is doing her PhD with the start-up AdjuTec Pharma AS and the Department of Pharmacy at the University of Oslo (UiO). Together, they will look for solutions to antibiotic resistance.
The Life Science Cluster and Oslo Cancer Cluster are collaborating on the competence broker-service for Oslo-based companies.
Tailored counseling, funding assistance, and innovation hangouts are part of the innovation package offered by the new Life Science Growth House at the University of Oslo.
Last year, we had the pleasure of welcoming 14 new members to Oslo Cancer Cluster. See who they are.
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.